G 2/21: how to support inventive steps in patentability

Post-published evidence can be crucial to establishing patentability. G 2/21, the European Patent Office (EPO)’s referral to the Enlarged Board of Appeal (EBA) on the question of whether post-published evidence can be used to support the concept of “inventive step”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Senior USPTO solicitor steps into private practice

14 January 2026 A high-profile departure from the USPTO sees a senior appellate expert move into private practice as demand increases in the firm's life sciences IP practice.

Careers

Goodwin targets transatlantic patent work with London hire

14 January 2026 The US firm has recruited a European patent attorney with three decades of experience to build its patent prosecution offering across the continent.

Europe

Bayer secures key Denmark ruling as Xarelto faces expiry pressure

13 January 2026 As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire.

More features

Goodwin targets transatlantic patent work with London hire

Bayer secures key Denmark ruling as Xarelto faces expiry pressure

Why the US is poised for a patent litigation surge in 2026

How AI will be shaped by legal and regulatory developments in 2026

‘All voices must be heard’: New CIPA president sets out plans for 2026

Edwards v Meril: Inside the UPC’s landmark medtech showdown

Key EU and UK regulatory changes to watch for in 2026

UPC: A review of 2025 and what to expect in 2026

G 2/21: how to support inventive steps in patentability

More on this story

Editor's picks

Editor's picks

More features